USCA RIA’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $3.38M | Buy |
24,975
+3,233
| +15% | +$438K | 0.21% | 141 |
|
|
2021
Q1 | $2.95M | Buy |
21,742
+1,330
| +7% | +$180K | 0.19% | 156 |
|
|
2020
Q4 | $2.87M | Buy |
20,412
+1,473
| +8% | +$207K | 0.2% | 102 |
|
|
2020
Q3 | $2.11M | Buy |
18,939
+1,831
| +11% | +$204K | 0.17% | 129 |
|
|
2020
Q2 | $1.92M | Sell |
17,108
-991
| -5% | -$111K | 0.17% | 125 |
|
|
2020
Q1 | $1.4M | Buy |
18,099
+1,737
| +11% | +$135K | 0.16% | 132 |
|
|
2019
Q4 | $1.56M | Sell |
16,362
-240
| -1% | -$22.8K | 0.14% | 198 |
|
|
2019
Q3 | $1.27M | Buy |
16,602
+800
| +5% | +$61K | 0.12% | 204 |
|
|
2019
Q2 | $1.39M | Buy |
15,802
+10,312
| +188% | +$904K | 0.14% | 190 |
|
|
2019
Q1 | $497K | Sell |
5,490
-895
| -14% | -$81K | 0.05% | 277 |
|
|
2018
Q4 | $458K | Buy |
6,385
+727
| +13% | +$52.1K | 0.06% | 270 |
|
|
2018
Q3 | $542K | Buy |
5,658
+470
| +9% | +$45K | 0.06% | 300 |
|
|
2018
Q2 | $494K | Buy |
5,188
+281
| +6% | +$26.8K | 0.05% | 301 |
|
|
2018
Q1 | $430K | Buy |
+4,907
| New | +$430K | 0.05% | 317 |
|